 |
0 Diseases |  |
137 Trials |
|
137 Trials |  |
5343 News |  |
| «12...79808182838485868788899091» |
- |||| Zemdri (plazomicin) / Ionis, Achaogen
Trial primary completion date: EPIC: A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP) (clinicaltrials.gov) - Apr 19, 2016
P3, N=530, Recruiting, Sponsor: Achaogen, Inc.
Trial primary completion date: May 2017 --> Jan 2017
- ||| New trial: A Multi-center Study for Eradication of Refractory Helicobacter Pylori (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=4428, Not yet recruiting, Sponsor: Taizhou Hospital
- | Enrollment open: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (clinicaltrials.gov) - Apr 15, 2016
P3, N=324, Recruiting, Sponsor: University Hospital, Tours
Trial primary completion date: May 2017 --> Jan 2017 Not yet recruiting --> Recruiting
- | New P4 trial: REMAP-CAP: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (clinicaltrials.gov) - Apr 13, 2016
P4, N=4000, Recruiting, Sponsor: UMC Utrecht
- |||| levofloxacin / Generic mfg.
Trial primary completion date: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (clinicaltrials.gov) - Apr 11, 2016
P3, N=740, Recruiting, Sponsor: Children's Oncology Group
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2016 --> Dec 2016
- levofloxacin / Generic mfg.
Enrollment change, Combination therapy: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) - Apr 11, 2016
P2, N=120, Recruiting, Sponsor: Boston University
Trial primary completion date: Jun 2016 --> Dec 2016 N=100 --> 120
- Vabomere (meropenem/vaborbactam) / Melinta Therap
Trial primary completion date: Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP (clinicaltrials.gov) - Apr 7, 2016
P3, N=850, Recruiting, Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
N=100 --> 120 Trial primary completion date: Jan 2016 --> Jun 2016
- || levofloxacin / Generic mfg., clarithromycin / Generic mfg.
New P3 trial, Head-to-Head: Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico. (clinicaltrials.gov) - Apr 1, 2016
P3, N=230, Completed, Sponsor: Asofarma de M
- || Gatiflox (gatifloxacin) / Orient Europharma, Besivance (besifloxacin ophthalmic suspension) / Bausch Health
New P3 trial: Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis (clinicaltrials.gov) - Mar 24, 2016
P3, N=252, Recruiting, Sponsor: University Hospital, Geneva
- | New P4 trial: Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection (clinicaltrials.gov) - Mar 18, 2016
P4, N=200, Not yet recruiting, Sponsor: Zahra Vahdat Shariatpanahi
- ||| levofloxacin / Generic mfg.
New trial: Non Interventional Study of Levofloxacin in Chronic Prostatitis (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=500, Completed, Sponsor: Dr. Reddy's Laboratories Limited
- ||| levofloxacin / Generic mfg., amoxycillin/clavulanate / Generic mfg.
New trial: Levolet: Levofloxacin in Bacterial Rhinosinussitis (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=100, Completed, Sponsor: Dr. Reddy's Laboratories Limited
- nitazoxanide / Generic mfg.
Trial primary completion date: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Mar 10, 2016
P3, N=100, Recruiting, Sponsor: Tanta University
Trial primary completion date: Jan 2016 --> Jun 2016 Trial primary completion date: Jan 2016 --> Sep 2016
- || New P3 trial: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (clinicaltrials.gov) - Mar 8, 2016
P3, N=324, Not yet recruiting, Sponsor: University Hospital, Tours
- levofloxacin / Generic mfg.
New P2 trial: Population Pharmacokinetics and Pharmacodynamics Modeling to Optimize Dosage Regimen of Levofloxacin (clinicaltrials.gov) - Mar 4, 2016
P2, N=45, Completed, Sponsor: Prince of Songkla University
- Enrollment change: Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - Feb 29, 2016
P4, N=1786, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Jan 2016 --> Sep 2016 N=1300 --> 1786
- ||||||| levofloxacin / Generic mfg., tigecycline / Generic mfg.
Trial completion: Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia (clinicaltrials.gov) - Feb 27, 2016
P3, N=434, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
N=1300 --> 1786 No longer recruiting --> Completed
- ||||||| levofloxacin / Generic mfg., tigecycline / Generic mfg.
Trial completion: Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia (clinicaltrials.gov) - Feb 27, 2016
P3, N=430, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| levofloxacin / Generic mfg.
Trial completion: Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media (clinicaltrials.gov) - Feb 27, 2016
P3, N=1643, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| levofloxacin / Generic mfg.
Trial completion: A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat (clinicaltrials.gov) - Feb 27, 2016
P3, N=206, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| levofloxacin / Generic mfg.
Trial completion: A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. (clinicaltrials.gov) - Feb 27, 2016
P3, N=659, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| levofloxacin / Generic mfg.
Trial completion: A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting (clinicaltrials.gov) - Feb 27, 2016
P3, N=691, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
No longer recruiting --> Completed No longer recruiting --> Completed
- | levofloxacin / Generic mfg., clarithromycin / Generic mfg.
New P4 trial: Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori (clinicaltrials.gov) - Feb 26, 2016
P4, N=100, Recruiting, Sponsor: Damascus Hospital
- ||| levofloxacin / Generic mfg., tetracycline / Generic mfg., esomeprazole / Generic mfg.
New trial: A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=3000, Not yet recruiting, Sponsor: First Affiliated Hospital of Zhejiang University
- | Sirturo (bedaquiline) / J&J, Pharmstandard
Enrollment open: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis (clinicaltrials.gov) - Feb 18, 2016
P2/3, N=300, Recruiting, Sponsor: University of Cape Town
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- Trial primary completion date: Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication (clinicaltrials.gov) - Feb 2, 2016
P4, N=450, Recruiting, Sponsor: National Taiwan University Hospital
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2015 --> May 2017
- |||| Taigexyn (nemonoxacin) / TaiGen
Trial primary completion date: A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP (clinicaltrials.gov) - Jan 17, 2016
P3, N=603, Active, not recruiting, Sponsor: TaiGen Biotechnology Co., Ltd.
Trial primary completion date: Oct 2015 --> May 2017 Trial primary completion date: Dec 2015 --> Dec 2016
- |||||| Zemdri (plazomicin) / Ionis, Achaogen
Enrollment open, Trial initiation date: EPIC: A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP) (clinicaltrials.gov) - Jan 15, 2016
P3, N=530, Recruiting, Sponsor: Achaogen, Inc.
Trial primary completion date: Dec 2015 --> Dec 2016 Not yet recruiting --> Recruiting | Initiation date: Sep 2015 --> Jan 2016
- levofloxacin / Generic mfg.
New trial: RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis (clinicaltrials.gov) - Jan 7, 2016
P=N/A, N=82, Not yet recruiting, Sponsor: Fu Xing Hospital, Capital Medical University
- || nitazoxanide / Generic mfg.
New P3 trial: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Dec 3, 2015
P3, N=100, Recruiting, Sponsor: Tanta University
- | prednisolone / Generic mfg., levofloxacin / Generic mfg.
New P4 trial: Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia (clinicaltrials.gov) - Dec 2, 2015
P4, N=80, Not yet recruiting, Sponsor: Seoul National University Hospital
- | New P2 trial: Treatment Shortening of MDR-TB Using Existing and New Drugs (clinicaltrials.gov) - Dec 2, 2015
P2, N=238, Not yet recruiting, Sponsor: Seoul National University Hospital
- ||||| Xerava (eravacycline) / SOM Biotech, Ewha Womans University, PAION, Innoviva
Enrollment closed, Trial primary completion date: Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections (clinicaltrials.gov) - Nov 24, 2015
P3, N=840, Active, not recruiting, Sponsor: Tetraphase Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting | Initiation date: Sep 2015 --> Jan 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Feb 2016
- | levofloxacin / Generic mfg., azithromycin / Generic mfg.
New P4 trial: Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients (clinicaltrials.gov) - Nov 9, 2015
P4, N=500, Recruiting, Sponsor: Fundaci
- New trial: Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication (clinicaltrials.gov) - Nov 5, 2015
P=N/A, N=200, Completed, Sponsor: Chang Gung Memorial Hospital
- ||||| Taigexyn (nemonoxacin) / TaiGen
Enrollment closed: A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP (clinicaltrials.gov) - Nov 5, 2015
P3, N=540, Active, not recruiting, Sponsor: TaiGen Biotechnology Co., Ltd.
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Feb 2016 Recruiting --> Active, not recruiting
- nitazoxanide / Generic mfg.
Trial primary completion date: Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori (clinicaltrials.gov) - Oct 27, 2015
P3, N=120, Recruiting, Sponsor: Sherief Abd-Elsalam
Recruiting --> Active, not recruiting Trial primary completion date: Oct 2015 --> Dec 2016
- |||||||||| levofloxacin / Generic mfg.
New P3 trial, Surgery: Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery (clinicaltrials.gov) - Oct 22, 2015
P3, N=430, Recruiting, Sponsor: Santen Pharmaceutical Co., Ltd.
- ||| Sufenta (sufentanil) / Akorn
New trial: Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO) (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=70, Recruiting, Sponsor: Yonsei University
- clarithromycin / Generic mfg.
New trial: Hepys (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=950, Not yet recruiting, Sponsor: Assistance Publique - H
- | Sirturo (bedaquiline) / J&J, Pharmstandard
Trial initiation date: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis (clinicaltrials.gov) - Sep 22, 2015
P2/3, N=300, Not yet recruiting, Sponsor: University of Cape Town
Trial primary completion date: Oct 2015 --> Dec 2016 Initiation date: Jun 2015 --> Oct 2015
- tobramycin/dexamethasone / Generic mfg., levofloxacin / Generic mfg.
New trial: Early Changes Among FLEx, LASIK and FS-LASIK (clinicaltrials.gov) - Sep 16, 2015
P=N/A, N=75, Recruiting, Sponsor: Sun Yat-sen University
- levofloxacin / Generic mfg., tetracycline / Generic mfg., esomeprazole / Generic mfg.
New trial: Comparison of Two Rescue Therapies for Helicobacter Pylori Infection (clinicaltrials.gov) - Sep 14, 2015
P=N/A, N=160, Recruiting, Sponsor: Kaohsiung Veterans General Hospital.
- New trial: Personalized Treatment for Refractory H Pylori Infection (clinicaltrials.gov) - Sep 14, 2015
P=N/A, N=150, Recruiting, Sponsor: Kaohsiung Veterans General Hospital.
- tobramycin/dexamethasone / Generic mfg., levofloxacin / Generic mfg.
New trial: Early Changes Between Lenticule Extraction and Small-Incision Lenticule Extraction (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=41, Completed, Sponsor: Sun Yat-sen University
- |||| ilaprazole / Generic mfg., levofloxacin / Generic mfg.
Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori (clinicaltrials.gov) - Aug 27, 2015
P4, N=320, Completed, Sponsor: Il-Yang Pharm. Co., Ltd.
Initiation date: Jun 2015 --> Oct 2015 Recruiting --> Completed | N=80 --> 320 | Initiation date: Dec 2014 --> Dec 2012 | Trial primary completion date: Dec 2015 --> Mar 2014
- levofloxacin / Generic mfg., cloxacillin / Generic mfg.
Trial termination: Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. (clinicaltrials.gov) - Aug 13, 2015
P3, N=1, Terminated, Sponsor: Fundaci
Recruiting --> Completed | N=80 --> 320 | Initiation date: Dec 2014 --> Dec 2012 | Trial primary completion date: Dec 2015 --> Mar 2014 Completed --> Terminated; Not participants inclusion
- levofloxacin / Generic mfg.
Enrollment open: BISER-2: Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=120, Recruiting, Sponsor: Guangzhou Institute of Respiratory Disease
Completed --> Terminated; Not participants inclusion Not yet recruiting --> Recruiting
- Sutent (sunitinib) / Pfizer
Trial completion: RISQ-PATH: Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=178, Completed, Sponsor: Katholieke Universiteit Leuven
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | levofloxacin / Generic mfg., prulifloxacin / Generic mfg.
Trial completion: A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control (clinicaltrials.gov) - Jul 16, 2015
P3, N=216, Completed, Sponsor: Lee's Pharmaceutical Limited
Active, not recruiting --> Completed Active, not recruiting --> Completed